What does TUYTTENS SCINTIMED do?

TUYTTENS SCINTIMED is filed with the CBE under the catch-all “Overige zakelijke dienstverlening”, a code that says little about what the company actually does. Private Limited, started on 27 February 2018, 1 establishment.

What is the address of TUYTTENS SCINTIMED?

The registered office of TUYTTENS SCINTIMED is located at Chemin des Maréchaux 8, 1300 Wavre.

Is TUYTTENS SCINTIMED still active?

Yes. According to the CBE (31 October 2026) TUYTTENS SCINTIMED is active, legal situation “Normale toestand”, started on 27 February 2018.

Is TUYTTENS SCINTIMED registered on Peppol?

Yes, TUYTTENS SCINTIMED is registered on the Peppol network with ID 0208:0690970491.

What is the enterprise number of TUYTTENS SCINTIMED?

The enterprise number of TUYTTENS SCINTIMED is BE0690970491.

When was TUYTTENS SCINTIMED founded?

TUYTTENS SCINTIMED was founded on 27 February 2018.

Who are the directors of TUYTTENS SCINTIMED?

According to the 2025 annual accounts, the directors of TUYTTENS SCINTIMED are: Nathalie TUYTTENS.

Is TUYTTENS SCINTIMED a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 27 February 2018; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did TUYTTENS SCINTIMED make in 2025?

TUYTTENS SCINTIMED posted a profit after taxes of € 109,744 in financial year 2025.

What is the revenue of TUYTTENS SCINTIMED?

As a small company, TUYTTENS SCINTIMED is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 151,541.

TUYTTENS SCINTIMED (Private Limited) - Wavre

Dossier TUYTTENS SCINTIMED, printed on 1 November 2026 from databakkes.be/en/0690970491/tuyttens-scintimed. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

TUYTTENS SCINTIMED from Wavre, company number BE0690970491, closed financial year 2025 with a result of € 109,744 after tax. For that financial year TUYTTENS SCINTIMED recorded a gross margin of € 151,541 and equity of € 1. Compared with financial year 2024, the result moved from € 98,821 to € 109,744. Profitable, and profit is growing. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on March 13, 2026.

What it is worth Growing

€ 1

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 109,744

▲ 11% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 111,016

▼ 54% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 109,744 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 135

▼ 98% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 6,192

▲ 45% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 111,956 Gross margin 2022: € 111,956 First fiscal year in the series	€ 131,645 Gross margin 2023: € 131,645 ▲ 18% vs 2022 (€ 111,956) Favourable step	€ 138,131 Gross margin 2024: € 138,131 ▲ 5% vs 2023 (€ 131,645) Favourable step	€ 151,541 Gross margin 2025: € 151,541 ▲ 10% vs 2024 (€ 138,131) Favourable step	▲ 10%
Profit after taxes	€ 78,274 Profit after taxes 2022: € 78,274 First fiscal year in the series	€ 93,256 Profit after taxes 2023: € 93,256 ▲ 19% vs 2022 (€ 78,274) Favourable step	€ 98,821 Profit after taxes 2024: € 98,821 ▲ 6% vs 2023 (€ 93,256) Favourable step	€ 109,744 Profit after taxes 2025: € 109,744 ▲ 11% vs 2024 (€ 98,821) Favourable step	▲ 11%
Equity	€ 271,355 Equity 2022: € 271,355 First fiscal year in the series	€ 141,412 Equity 2023: € 141,412 ▼ 48% vs 2022 (€ 271,355) Unfavourable step	€ 0 Equity 2024: € 0 ▼ 100% vs 2023 (€ 141,412) Unfavourable step	€ 1 Equity 2025: € 1 Unchanged (€ 0) Favourable step
Total debts	€ 81,101 Total debts 2022: € 81,101 First fiscal year in the series	€ 229,644 Total debts 2023: € 229,644 ▲ 183% vs 2022 (€ 81,101) Unfavourable step	€ 253,021 Total debts 2024: € 253,021 ▲ 10% vs 2023 (€ 229,644) Unfavourable step	€ 126,879 Total debts 2025: € 126,879 ▼ 50% vs 2024 (€ 253,021) Favourable step	▼ 50%
Cash	€ 316,962 Cash 2022: € 316,962 First fiscal year in the series	€ 348,586 Cash 2023: € 348,586 ▲ 10% vs 2022 (€ 316,962) Favourable step	€ 242,457 Cash 2024: € 242,457 ▼ 30% vs 2023 (€ 348,586) Unfavourable step	€ 111,016 Cash 2025: € 111,016 ▼ 54% vs 2024 (€ 242,457) Unfavourable step	▼ 54%
Retained profit	€ 271,355 Retained profit 2022: € 271,355 First fiscal year in the series	€ 141,412 Retained profit 2023: € 141,412 ▼ 48% vs 2022 (€ 271,355) Unfavourable step	€ 0 Retained profit 2024: € 0 ▼ 100% vs 2023 (€ 141,412) Unfavourable step	€ 0 Retained profit 2025: € 0 Unchanged (€ 0) Unchanged
Dividend	€ 78,274 Dividend 2022: € 78,274 First fiscal year in the series	€ 223,199 Dividend 2023: € 223,199 ▲ 185% vs 2022 (€ 78,274) Unchanged	€ 240,233 Dividend 2024: € 240,233 ▲ 8% vs 2023 (€ 223,199) Unchanged	€ 109,744 Dividend 2025: € 109,744 ▼ 54% vs 2024 (€ 240,233) Unchanged	▼ 54%
Balance sheet total	€ 352,457 Balance sheet total 2022: € 352,457 First fiscal year in the series	€ 371,056 Balance sheet total 2023: € 371,056 ▲ 5% vs 2022 (€ 352,457) Unchanged	€ 253,021 Balance sheet total 2024: € 253,021 ▼ 32% vs 2023 (€ 371,056) Unchanged	€ 126,880 Balance sheet total 2025: € 126,880 ▼ 50% vs 2024 (€ 253,021) Unchanged	▼ 50%

Key figures of TUYTTENS SCINTIMED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to TUYTTENS SCINTIMED?

What happened at TUYTTENS SCINTIMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 13, 2026 New annual accounts for financial year 2025: profit of € 109,744 (▲ 11% vs 2024). Source: NBB ↗
Feb 27, 2018 New establishment in Wavre. KBO
2018 Nathalie TUYTTENS became a director. NBB
Feb 27, 2018 Start of the company according to the CBE. KBO

In short

From € 78,274 profit in 2022 to € 109,744 profit in 2025.

Paid € 111,412 in corporate taxes since 2022.

Best year ever: 2025, with € 109,744 profit.

Paid out € 651,450 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Nathalie TUYTTENS

TUYTTENS SCINTIMED

Behind TUYTTENS SCINTIMED is Nathalie TUYTTENS.

Directors

According to the 2025 annual accounts

Nathalie TUYTTENS

Director

since 2018

Establishments

Establishment units

Physical locations of this company

Registered office

Chemin des Maréchaux 8

1300 Wavre

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0690.970.491
VAT number: BE 0690.970.491
Registered office: Chemin des Maréchaux 8, 1300 Wavre
Names & denominations: TUYTTENS SCINTIMED
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 27 February 2018
Peppol: Active · Active since 15 Sept 2025
Activities · NACE: Overige zakelijke dienstverlening, neg

View on CBE Public ↗ Annual accounts (NBB) ↗